Steve Dubin

Mr. Steve Dubin is the Former CEO of Martek Biosciences Corporation (NASDAQ: MATK). Mr. Dubin played a key role in developing Martek’s business from an R&D company to a fully integrated, profitable, commercial organization with over $470M in annual sales. In December of 20120, Martek was acquired by Royal DSM N.V. for $1.1 billion. Mr. Dubin is a Principal at SDA Ventures LLC.